JB/CALL/ROCHE GS/275/0.02/21.06.24 Share Price

Warrant

ROVFJB

CH1242789225

Market Closed - Swiss Exchange 16:15:01 16/05/2024 BST
0.004 CHF +33.33% Intraday chart for JB/CALL/ROCHE GS/275/0.02/21.06.24
6 months-90.00%
Current year-92.00%

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying ROCHE HOLDING AG
Issuer Bank Julius Bär
ROVFJB
ISINCH1242789225
Date issued 31/01/2023
Strike 275 CHF
Maturity 21/06/2024 (28 Days)
Parity 50 : 1
Emission price 0.55 CHF
Emission volume N/A
Settlement both
Currency CHF

Technical Indicators

Highest since issue 0.65 CHF
Lowest since issue 0.003 CHF
Spread 0.003 CHF
Spread %75.00%

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
230.4 CHF
Average target price
279.8 CHF
Spread / Average Target
+21.46%
Consensus
  1. Stock Market
  2. Warrants
  3. ROVFJB Warrant